173 related articles for article (PubMed ID: 23477870)
1. Increased antibody response to microbial antigens in patients with Crohn's disease and their unaffected first-degree relatives.
Michielan A; Basso D; Martinato M; Pathak S; Banerjee A; Oliva L; Plebani M; Sturniolo GC; D'Incà R
Dig Liver Dis; 2013 Nov; 45(11):894-8. PubMed ID: 23477870
[TBL] [Abstract][Full Text] [Related]
2. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease.
Dotan I; Fishman S; Dgani Y; Schwartz M; Karban A; Lerner A; Weishauss O; Spector L; Shtevi A; Altstock RT; Dotan N; Halpern Z
Gastroenterology; 2006 Aug; 131(2):366-78. PubMed ID: 16890590
[TBL] [Abstract][Full Text] [Related]
3. NOD2 variants and antibody response to microbial antigens in Crohn's disease patients and their unaffected relatives.
Devlin SM; Yang H; Ippoliti A; Taylor KD; Landers CJ; Su X; Abreu MT; Papadakis KA; Vasiliauskas EA; Melmed GY; Fleshner PR; Mei L; Rotter JI; Targan SR
Gastroenterology; 2007 Feb; 132(2):576-86. PubMed ID: 17258734
[TBL] [Abstract][Full Text] [Related]
4. Mutations in pattern recognition receptor genes modulate seroreactivity to microbial antigens in patients with inflammatory bowel disease.
Henckaerts L; Pierik M; Joossens M; Ferrante M; Rutgeerts P; Vermeire S
Gut; 2007 Nov; 56(11):1536-42. PubMed ID: 17595233
[TBL] [Abstract][Full Text] [Related]
5. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease.
Mow WS; Vasiliauskas EA; Lin YC; Fleshner PR; Papadakis KA; Taylor KD; Landers CJ; Abreu-Martin MT; Rotter JI; Yang H; Targan SR
Gastroenterology; 2004 Feb; 126(2):414-24. PubMed ID: 14762777
[TBL] [Abstract][Full Text] [Related]
6. Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease.
Sendid B; Quinton JF; Charrier G; Goulet O; Cortot A; Grandbastien B; Poulain D; Colombel JF
Am J Gastroenterol; 1998 Aug; 93(8):1306-10. PubMed ID: 9707056
[TBL] [Abstract][Full Text] [Related]
7. New serological markers in inflammatory bowel disease are associated with complicated disease behaviour.
Ferrante M; Henckaerts L; Joossens M; Pierik M; Joossens S; Dotan N; Norman GL; Altstock RT; Van Steen K; Rutgeerts P; Van Assche G; Vermeire S
Gut; 2007 Oct; 56(10):1394-403. PubMed ID: 17456509
[TBL] [Abstract][Full Text] [Related]
8. Familial expression of anti-Escherichia coli outer membrane porin C in relatives of patients with Crohn's disease.
Mei L; Targan SR; Landers CJ; Dutridge D; Ippoliti A; Vasiliauskas EA; Papadakis KA; Fleshner PR; Rotter JI; Yang H
Gastroenterology; 2006 Apr; 130(4):1078-85. PubMed ID: 16618402
[TBL] [Abstract][Full Text] [Related]
9. Serum antibodies in first-degree relatives of patients with IBD: a marker of disease susceptibility? A follow-up pilot-study after 7 years.
Török HP; Glas J; Hollay HC; Gruber R; Osthoff M; Tonenchi L; Brückl C; Mussack T; Folwaczny M; Folwaczny C
Digestion; 2005; 72(2-3):119-23. PubMed ID: 16172548
[TBL] [Abstract][Full Text] [Related]
10. Familial expression of anti-Saccharomyces cerevisiae Mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study.
Annese V; Andreoli A; Andriulli A; Dinca R; Gionchetti P; Latiano A; Lombardi G; Piepoli A; Poulain D; Sendid B; Colombel JF
Am J Gastroenterol; 2001 Aug; 96(8):2407-12. PubMed ID: 11513182
[TBL] [Abstract][Full Text] [Related]
11. Anti-Saccharomyces cerevisiae mannan antibodies in inflammatory bowel disease: comparison of different assays and correlation with clinical features.
Annese V; Piepoli A; Perri F; Lombardi G; Latiano A; Napolitano G; Corritore G; Vandewalle P; Poulain D; Colombel JF; Andriulli A
Aliment Pharmacol Ther; 2004 Nov; 20(10):1143-52. PubMed ID: 15569117
[TBL] [Abstract][Full Text] [Related]
12. Antineutrophil cytoplasmic antibodies in relatives of patients with inflammatory bowel disease.
Papo M; Quer JC; Pastor RM; García-Pardo G; Prats E; Mirapeix E; Rodríguez R; Richart C
Am J Gastroenterol; 1996 Aug; 91(8):1512-5. PubMed ID: 8759652
[TBL] [Abstract][Full Text] [Related]
13. Concordance in Anti-OmpC and Anti-I2 Indicate the Influence of Genetic Predisposition: Results of a European Study of Twins with Crohn's Disease.
Amcoff K; Joossens M; Pierik MJ; Jonkers D; Bohr J; Joossens S; Romberg-Camps M; Nyhlin N; Wickbom A; Rutgeerts PJ; Tysk C; Bodin L; Colombel JF; Vermeire S; Halfvarson J
J Crohns Colitis; 2016 Jun; 10(6):695-702. PubMed ID: 26818662
[TBL] [Abstract][Full Text] [Related]
14. Sero-reactivity to microbial components in Crohn's disease is associated with disease severity and progression, but not NOD2/CARD15 genotype.
Arnott ID; Landers CJ; Nimmo EJ; Drummond HE; Smith BK; Targan SR; Satsangi J
Am J Gastroenterol; 2004 Dec; 99(12):2376-84. PubMed ID: 15571586
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of breast cancer in first-degree relatives of Crohn's disease patients. An IG-IBD study.
Riegler G; Caserta L; Castiglione F; Esposito I; Valpiani D; Annese V; Zoli G; Gionchetti P; Viscido A; Sturniolo GC; Rispo A; De Filippo FR; de Leone A; Carratu R;
Dig Liver Dis; 2006 Jan; 38(1):18-23. PubMed ID: 16169781
[TBL] [Abstract][Full Text] [Related]
16. New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2/CARD15 genotype in a Hungarian IBD cohort.
Papp M; Altorjay I; Dotan N; Palatka K; Foldi I; Tumpek J; Sipka S; Udvardy M; Dinya T; Lakatos L; Kovacs A; Molnar T; Tulassay Z; Miheller P; Norman GL; Szamosi T; Papp J; ; Lakatos PL
Am J Gastroenterol; 2008 Mar; 103(3):665-81. PubMed ID: 18047543
[TBL] [Abstract][Full Text] [Related]
17. Anti-Microbial Antibody Response is Associated With Future Onset of Crohn's Disease Independent of Biomarkers of Altered Gut Barrier Function, Subclinical Inflammation, and Genetic Risk.
Lee SH; Turpin W; Espin-Garcia O; Raygoza Garay JA; Smith MI; Leibovitzh H; Goethel A; Turner D; Mack D; Deslandres C; Cino M; Aumais G; Panaccione R; Jacobson K; Bitton A; Steinhart AH; Huynh HQ; Princen F; Moayyedi P; Griffiths AM; Silverberg MS; Paterson AD; Xu W; Croitoru K;
Gastroenterology; 2021 Nov; 161(5):1540-1551. PubMed ID: 34293299
[TBL] [Abstract][Full Text] [Related]
18. Interaction between seroreactivity to microbial antigens and genetics in Crohn's disease: is there a role for defensins?
Lakatos PL; Altorjay I; Mándi Y; Lakatos L; Tumpek J; Kovacs A; Molnar T; Tulassay Z; Miheller P; Palatka K; Szamosi T; Fischer S; Papp J; ; Papp M
Tissue Antigens; 2008 Jun; 71(6):552-9. PubMed ID: 18397186
[TBL] [Abstract][Full Text] [Related]
19. Genetic and serological markers to identify phenotypic subgroups in a Dutch Crohn' s disease population.
Linskens RK; Mallant-Hent RC; Murillo LS; von Blomberg BM; Alizadeh BZ; Peña AS
Dig Liver Dis; 2004 Jan; 36(1):29-34. PubMed ID: 14971813
[TBL] [Abstract][Full Text] [Related]
20. New serologic markers for inflammatory bowel disease diagnosis.
Dotan I
Dig Dis; 2010; 28(3):418-23. PubMed ID: 20926866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
